State of Wyoming - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of Wyoming ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$345,252
+18.0%
9,038
+11.4%
0.07%
-12.9%
Q2 2023$292,600
+114.4%
8,112
+127.0%
0.08%
+93.2%
Q1 2023$136,491
-39.5%
3,574
-9.9%
0.04%
-41.3%
Q4 2022$225,665
+35.1%
3,966
-6.2%
0.08%
-8.5%
Q3 2022$167,000
-13.9%
4,226
-4.1%
0.08%
-31.7%
Q2 2022$194,000
-41.0%
4,407
-46.6%
0.12%
-27.3%
Q1 2022$329,000
-20.7%
8,256
-20.0%
0.16%
-14.5%
Q4 2021$415,000
+24.3%
10,321
+25.6%
0.19%
-10.2%
Q3 2021$334,000
+18.4%
8,215
+32.5%
0.22%
+20.8%
Q2 2021$282,0006,2000.18%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders